Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

Clinical trial NCT00868192 · COMPLETED

Trial details

NCT number: NCT00868192
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Carcinoma Primary Peritoneal Carcinoma

Start date: 2008-05-01
Primary completion: 2012-12-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.